Current Rheumatology Reviews

Scope & Guideline

Pioneering insights for modern rheumatology.

Introduction

Welcome to your portal for understanding Current Rheumatology Reviews, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1573-3971
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCURR RHEUMATOL REV / Curr. Rheumatol. Rev.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Rheumatology Reviews focuses on advancing the understanding of rheumatic diseases through innovative research, clinical insights, and therapeutic strategies. The journal aims to integrate basic science with clinical practice, providing a comprehensive platform for researchers and clinicians alike.
  1. Clinical Management of Rheumatic Diseases:
    The journal emphasizes research on the diagnosis, management, and treatment of various rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and more. It aims to address both traditional and novel therapeutic approaches.
  2. Genetic and Molecular Insights:
    Research articles frequently explore genetic polymorphisms, biomarkers, and molecular mechanisms underlying rheumatic diseases, contributing to a better understanding of disease pathogenesis and potential targets for therapy.
  3. Patient Quality of Life and Health Outcomes:
    A significant focus is placed on studies assessing the impact of rheumatic diseases on patients' quality of life, functional ability, and psychological well-being, highlighting the importance of holistic patient care.
  4. Emerging Therapies and Innovative Treatments:
    The journal covers novel therapeutic strategies, including biologics, small molecules, and complementary approaches, providing insights into the latest advancements in treatment options for rheumatic conditions.
  5. Epidemiological Studies and Public Health:
    Current Rheumatology Reviews includes epidemiological research that examines the prevalence, risk factors, and health disparities related to rheumatic diseases, contributing to public health knowledge and policy.
Current Rheumatology Reviews has identified several emerging themes and trends that reflect the evolving landscape of rheumatology research and clinical practice, highlighting areas of increasing interest.
  1. Precision Medicine and Personalized Therapy:
    There is a growing emphasis on precision medicine approaches, exploring how genetic, environmental, and lifestyle factors can be integrated into personalized treatment plans for patients with rheumatic diseases.
  2. Impact of COVID-19 on Rheumatic Diseases:
    The journal has seen a surge in research exploring the effects of COVID-19 on patients with rheumatic conditions, including disease activity and treatment responses, reflecting the pandemic's profound impact on healthcare.
  3. Role of the Microbiome in Rheumatic Diseases:
    Emerging studies are increasingly investigating the connections between the microbiome and autoimmune diseases, suggesting a novel area of research that may lead to innovative therapeutic strategies.
  4. Use of Digital Health Technologies:
    The integration of digital health technologies, such as telemedicine and mobile health applications, is becoming a prominent theme, focusing on improving patient management and access to care.
  5. Interdisciplinary Approaches to Rheumatology:
    There is a trend towards interdisciplinary research that combines rheumatology with other fields such as neurology, cardiology, and endocrinology, addressing the complex interplay of comorbidities in rheumatic diseases.

Declining or Waning

While Current Rheumatology Reviews has maintained a robust focus on various aspects of rheumatology, certain themes have shown a decline in publication frequency over recent years, indicating shifting research priorities.
  1. Traditional Therapies and Older Treatments:
    There has been a noticeable decrease in studies focusing on older treatment modalities, such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, as newer therapies gain prominence.
  2. Aging-Related Rheumatic Conditions:
    Research specifically addressing aging-related rheumatic conditions has waned, suggesting a shift towards more contemporary issues in rheumatology such as autoimmunity and genetic predispositions.
  3. Basic Science Research:
    There is a declining trend in purely basic science studies that do not directly connect to clinical applications, as the journal increasingly emphasizes translational research that links laboratory findings to patient care.
  4. Generalized Epidemiological Surveys:
    While epidemiological research remains important, there appears to be a decline in generalized surveys that do not focus on specific populations or diseases, favoring more targeted studies.

Similar Journals

Indian Journal of Rheumatology

Championing research that transforms rheumatologic practices.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Open Access Rheumatology-Research and Reviews

Empowering Researchers with Open Access Insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Modern Rheumatology

Navigating the Frontiers of Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Egyptian Rheumatologist

Exploring innovations in autoimmune disease management.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

LUPUS

Advancing understanding in lupus and autoimmune research.
Publisher: SAGE PUBLICATIONS LTDISSN: 0961-2033Frequency: 14 issues/year

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

Archives of Rheumatology

Empowering researchers to reshape rheumatic disease management.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Current Treatment Options in Rheumatology

Navigating the complexities of rheumatic treatments with expert reviews.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

JOURNAL OF RHEUMATOLOGY

Advancing the Frontiers of Rheumatology and Immunology
Publisher: J RHEUMATOL PUBL COISSN: 0315-162XFrequency: 12 issues/year

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

Pediatric Rheumatology

Exploring the forefront of child health and rheumatology.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders

Advancing research for better musculoskeletal health.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5441Frequency: 1 issue/year

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.